The largest database of trusted experimental protocols

Anti inos antibody

Manufactured by Merck Group
Sourced in United States

The Anti-iNOS antibody is a laboratory tool used to detect the presence and quantity of the inducible nitric oxide synthase (iNOS) protein in biological samples. iNOS is an enzyme involved in the production of nitric oxide, which plays a role in various physiological and pathological processes. The antibody allows researchers to measure iNOS levels and monitor its expression in cells or tissues, providing a valuable tool for studying the involvement of nitric oxide signaling in different biological systems.

Automatically generated - may contain errors

8 protocols using anti inos antibody

1

Flow Cytometry Analysis of Immune Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
All infected and uninfected tissues were dissociated by collagenase digestion as described previously 40 (link). Cell suspensions were stained and analyzed by flow cytometry. The following antibodies were used for cell surface staining: anti-CD11b (clone M1/70), anti-CD11c (clone N418), anti-CD3 (145-2C11), anti-Ly6C (HK1.4), anti-MHCII (M5/114.15.2), anti-CD19 (ebio1D3), anti-NK1.1 (PK136), anti-siglecH (ebio440c), anti-B220 (RA3-6B2), anti-CD4 (GK.5), anti-CD8 (53-6.7) and anti-CD69 (H1.2F3) were purchased from eBioscience, anti-Ly6G (1A8) was obtained from BD Pharmingen, anti-Ly6-B2 antibody (7/4) from AbD Serotec, and CCR2 (475301) from R&D Systems. For intracellular staining: anti-iNOS antibody was purchased from Millipore, and anti-TNF-α (MP6-XT22) was purchased from BD Pharmingen. Cell suspensions from collagenase-digested tissue were stained for cell surface markers and permeabilized using the BD Cytofix/Cytoperm Kit (BD Pharmingen). For detection of intracellular TNF-α, cells were also treated ex vivo with GolgiPlug (BD Pharmingen) for 6 h at 37°C in complete RPMI medium prior to cell surface staining and stained according to the manufacturers instructions. Acquisitions were performed with a BD LSRII, and data were analyzed with the FlowJo software.
+ Open protocol
+ Expand
2

Western Blot Analysis of Nitric Oxide Synthases

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were homogenized in lysis buffer on ice, then centrifuged at 12,000 rpm for 10 min (4°C). Supernatants were collected and protein concentration was determined using a BCA assay. Proteins (5 μg) were separated by 10% SDS-PAGE under reducing conditions and electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane (Amersham Bio-sciences, Freiburg, Germany). Membranes were blocked in a TBST (Tris-buffer saline containing 0.05% Tween-20) solution containing 5% nonfat milk and then probed (4°C; overnight) with an anti-nNOS antibody (1:500, Epitomics, Burlingame, CA, USA), an anti-iNOS antibody (1:500, Millipore Corp, billerica, MA, USA), or an anti-GAPDH antibody (1:1000, Sigma Chemical Co, St. Louis, MO, USA), diluted in TBST containing 5% nonfat milk. Following washes in TBST buffer, horseradish peroxidase-conjugated secondary antibody (1:2000, ZSGB-BIO, ORIGENE, Beijing, China) was used to detect primary antibodies (2 h at room temperature). ECL plus reagent was used to develop films and the intensity of bands was determined by Gel-Pol analyzer.
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Immune Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
All infected and uninfected tissues were dissociated by collagenase digestion as described previously 40 (link). Cell suspensions were stained and analyzed by flow cytometry. The following antibodies were used for cell surface staining: anti-CD11b (clone M1/70), anti-CD11c (clone N418), anti-CD3 (145-2C11), anti-Ly6C (HK1.4), anti-MHCII (M5/114.15.2), anti-CD19 (ebio1D3), anti-NK1.1 (PK136), anti-siglecH (ebio440c), anti-B220 (RA3-6B2), anti-CD4 (GK.5), anti-CD8 (53-6.7) and anti-CD69 (H1.2F3) were purchased from eBioscience, anti-Ly6G (1A8) was obtained from BD Pharmingen, anti-Ly6-B2 antibody (7/4) from AbD Serotec, and CCR2 (475301) from R&D Systems. For intracellular staining: anti-iNOS antibody was purchased from Millipore, and anti-TNF-α (MP6-XT22) was purchased from BD Pharmingen. Cell suspensions from collagenase-digested tissue were stained for cell surface markers and permeabilized using the BD Cytofix/Cytoperm Kit (BD Pharmingen). For detection of intracellular TNF-α, cells were also treated ex vivo with GolgiPlug (BD Pharmingen) for 6 h at 37°C in complete RPMI medium prior to cell surface staining and stained according to the manufacturers instructions. Acquisitions were performed with a BD LSRII, and data were analyzed with the FlowJo software.
+ Open protocol
+ Expand
4

Investigating LPS-Induced Inflammatory Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lipopolysaccharide (LPS) from Salmonella enterica serotype typhimurium and the Griess reagent (G4410) were purchased from Sigma-Aldrich Chemical Co. (USA). The anti-iNOS antibody was purchased from Millipore (USA), and anti-β-actin antibody was purchased from Santa Cruz Biotechnology (USA).
We procured 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), ammonium pyrrolidinedithiocarbamate (APDTC), protease inhibitor cocktail from Merck (Germany). Dulbecco's modified Eagle medium (DMEM), fetal bovine serum (FBS), penicillin/ streptomycin, trypsin-ethylenediaminetetraacetic acid, BCA protein assay kit were purchased from Thermo Fisher Scientific (USA). Dimethyl sulfoxide (DMSO), radioimmunoprecipitation (RIPA) buffer, and enhanced chemiluminescence (ECL) kit were purchased from Biosesang (Korea) and Laemmli sample buffer (2X) was purchased from Bio-Rad (USA).
+ Open protocol
+ Expand
5

Western Blot Analysis of Neuroinflammatory Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For western blotting analysis, tissue extracts were prepared by homogenizing mouse hippocampus tissue in T-PER Tissue Protein Extraction Reagent (Thermo Scientific Inc., Waltham, MA, USA) containing protease inhibitor, α-complete (Roche Applied Science, Penzberg, Germany). Fifteen micrograms of each tissue extract sample were adjusted to give a final solution of 60 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 0.1% bromophenol blue, and 5% β-mercaptoethanol. The solution was heated at 100ºC for 5 min, electrophoresed through a 10% SDS-polyacrylamide gel, and transferred to polyvinylidine difluoride membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK). Plexin-A1, Neuropilin-1, COX-2, iNOS, IL-1β, TNF-α and β-actin were detected by their respective antibodies using an enhanced chemiluminescence western blot detection system (Amersham Pharmacia Biotech) according to the manufacturer’s instructions. Anti-Plexin-A1 antibody (Abcam), anti-Neuropilin-1 antibody (Abcam), anti-COX-2 antibody (Santa Cruz Biotechnology, Inc., Dallas, Texas, USA), anti-iNOS antibody (Merck Millipore, Darmstadt, Germany), anti-IL-1β antibody (Santa Cruz Biotechnology), anti-TNF-α antibody (Santa Cruz Biotechnology), and anti-β-actin antibody (Cell Signaling Technology, Danvers, MA, USA) were used.
+ Open protocol
+ Expand
6

Immunoblotting Analysis of iNOS Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treated-RAW 264.7 cells were collected and lysed with RIPA buffer containing protease inhibitors. The protein samples were subjected to 10% SDS-PAGE and transferred to a nitrocellulose membrane. The target proteins were probed with specific antibodies, an anti-iNOS antibody at a dilution of 1:2000 (Merck, Rahway, NJ, USA), and an anti- β-actin antibody at a dilution of 1:10,000 (Sigma, St. Louis, MO, USA). Protein detection was carried out using a chemiluminescence reagent.
+ Open protocol
+ Expand
7

Quantitative Measurement of iNOS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iNOS contents were determined using the method described previously by Marshall et al. [29 (link)] and modified by Saia et al. [18 (link)]. The macrophage homogenates were diluted in phosphate-buffered saline (PBS 0.1 M, pH 7.2) and incubated overnight at 4°C in Nunc Maxisorb plates (Life Technologies, Paisley, UK). The wells were washed with PBS containing 0.05% Tween-20 (PBS-T) and blocked with 1% (w/v) bovine serum albumin (BSA) for 1 h at room temperature. Subsequently, the polyclonal rabbit anti-iNOS antibody (1:1000; Sigma) was added for 1 h at room temperature. After washing, the biotinylated anti-rabbit IgG secondary antibody (1:200; Vector Laboratories) was added to each well, incubated with avidin-HRP (1:5000; Sigma) for 30 min, and the colour developed by addition of 3,3′,5,5′-tetramethylbenzidine substrate (TMB; BD Biosciences, Franklin Lakes, NJ, USA). The reaction was stopped with 2 N H2SO4 and the optical density (OD) reading at 450 nm was taken. The sample levels of iNOS were expressed as OD normalized to the respective total protein concentrations.
+ Open protocol
+ Expand
8

Inhibition of LPS-induced iNOS and COX-2 in RAW 264.7 cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW 264.7 cells were seeded at a density of 5 × 105 cells/mL in a 6-well plate. After overnight incubation, they were pretreated with different concentrations of ETMI for 1 h before the addition of LPS (0.5 μg/mL). After incubation for 24 h, the cells were collected and lysed in radioimmunoprecipitation assay (RIPA) buffer. Western blotting was performed as previously described 19 (link). Anti-iNOS antibody was purchased from Sigma-Aldrich (Cat# N7782), and anti-COX-2 and anti-β-actin antibodies were obtained from Cell Signaling (Cat# 4842 and Cat# 3700, respectively). Immunoblot signals were compared with those for β-actin and the relative protein expression was determined.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!